Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy COMPASS Pathways stock | $36.65

Learn how to easily invest in COMPASS Pathways stock.

COMPASS Pathways plc
-$1.54 (-4.34%)

COMPASS Pathways plc (CMPS) is a leading other business based in the US. It opened the day at $35.77 after a previous close of $33.91. During the day the price has varied from a low of $35.10 to a high of $37.02. The latest price was $36.65 (25 minute delay). COMPASS Pathways is listed on the NASDAQ and employs 61 staff. All prices are listed in US Dollars.

How to buy shares in COMPASS Pathways

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CMPS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

COMPASS Pathways stock price (NASDAQ: CMPS)

Use our graph to track the performance of CMPS stocks over time.

COMPASS Pathways shares at a glance

Information last updated 2021-07-09.
Previous close$33.91
Change $2.74
Change % 8.0802%
Volume 569,575
Information last updated 2021-07-28.
52-week range$22.51 - $61.69
50-day moving average $36.53
200-day moving average $39.07
Wall St. target price$72.88
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy COMPASS Pathways shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy COMPASS Pathways stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

COMPASS Pathways price performance over time

Historical closes compared with the close of $36.65 from 2021-05-28

1 week (2021-07-22) N/A
1 month (2021-07-02) -1.66%
3 months (2021-04-30) 0.99%
6 months (2021-01-29) N/A
1 year (2020-07-29) N/A
2 years (2019-07-29) N/A
3 years (2018-07-29) N/A
5 years (2016-07-29) N/A

COMPASS Pathways financials

Gross profit TTM $0
Return on assets TTM -29.06%
Return on equity TTM -67.93%
Profit margin 0%
Book value $5.13
Market capitalisation $1.5 billion

TTM: trailing 12 months

Shorting COMPASS Pathways shares

There are currently 467,120 COMPASS Pathways shares held short by investors – that's known as COMPASS Pathways's "short interest". This figure is 64.1% down from 1.3 million last month.

There are a few different ways that this level of interest in shorting COMPASS Pathways shares can be evaluated.

COMPASS Pathways's "short interest ratio" (SIR)

COMPASS Pathways's "short interest ratio" (SIR) is the quantity of COMPASS Pathways shares currently shorted divided by the average quantity of COMPASS Pathways shares traded daily (recently around 491705.26315789). COMPASS Pathways's SIR currently stands at 0.95. In other words for every 100,000 COMPASS Pathways shares traded daily on the market, roughly 950 shares are currently held short.

To gain some more context, you can compare COMPASS Pathways's short interest ratio against those of similar companies.

However COMPASS Pathways's short interest can also be evaluated against the total number of COMPASS Pathways shares, or, against the total number of tradable COMPASS Pathways shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0.021% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 21 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against COMPASS Pathways.

Find out more about how you can short COMPASS Pathways stock.

COMPASS Pathways share dividends

We're not expecting COMPASS Pathways to pay a dividend over the next 12 months.

COMPASS Pathways overview

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin formulation that is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. .

Frequently asked questions

What percentage of COMPASS Pathways is owned by insiders or institutions?
Currently 4.51% of COMPASS Pathways shares are held by insiders and 12.634% by institutions.
How many people work for COMPASS Pathways?
Latest data suggests 61 work at COMPASS Pathways.
When does the fiscal year end for COMPASS Pathways?
COMPASS Pathways's fiscal year ends in December.
Where is COMPASS Pathways based?
COMPASS Pathways's address is: 1 Ashley Road, Altrincham, United Kingdom, WA14 2DT
What is COMPASS Pathways's ISIN number?
COMPASS Pathways's international securities identification number is: US20451W1018

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site